LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

Strona główna・Stock List・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Closed

SectorHealthcare

24.89 10.82

Buy Sell

Overview

Share price change

24h

Current

Min

21.77

Max

25.91

Key metrics
By Trading Economics
Income	-1.8M -21M
Sales	4.1M 83M
Profit margin	-25.695
Employees	756
EBITDA	4.8M -19M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+30.15% upside

Dividends
By Dow Jones
Next Earnings	23 kwi 2026

Market Stats
By TradingEconomics
Market Cap	-391M 1.5B
Previous open	14.07
Previous close	24.89

News Sentiment

By Acuity

100%

336 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

52.655 / 56.31 Support & Resistance

PROCEPT BioRobotics Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 mar 2026, 23:41 UTC

Market Talk

Major News Events

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2 mar 2026, 23:37 UTC

Market Talk

Major News Events

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2 mar 2026, 23:26 UTC

Major News Events

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2 mar 2026, 22:41 UTC

Market Talk

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2 mar 2026, 22:32 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 22:32 UTC

Market Talk

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2 mar 2026, 22:21 UTC

Market Talk

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2 mar 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

2 mar 2026, 22:11 UTC

Market Talk

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2 mar 2026, 22:10 UTC

Acquisitions, Mergers, Takeovers

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2 mar 2026, 22:06 UTC

Market Talk

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2 mar 2026, 22:00 UTC

Market Talk

Earnings

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 22:00 UTC

Market Talk

Earnings

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2 mar 2026, 21:50 UTC

Market Talk

Major News Events

Energy & Utilities Roundup: Market Talk

2 mar 2026, 21:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

2 mar 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

2 mar 2026, 21:35 UTC

Acquisitions, Mergers, Takeovers

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2 mar 2026, 21:34 UTC

Acquisitions, Mergers, Takeovers

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2 mar 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mar 2026, 21:17 UTC

Major News Events

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2 mar 2026, 20:44 UTC

Earnings

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mar 2026, 20:43 UTC

Market Talk

Major News Events

Treasury Yields Fall, Dollar Strengthens After Attack on Iran -- Market Talk

2 mar 2026, 20:28 UTC

Earnings

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2 mar 2026, 20:25 UTC

Market Talk

Major News Events

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2 mar 2026, 20:24 UTC

Earnings

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mar 2026, 20:14 UTC

Acquisitions, Mergers, Takeovers

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mar 2026, 20:12 UTC

Major News Events

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2 mar 2026, 20:08 UTC

Market Talk

Major News Events

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 20:08 UTC

Market Talk

Major News Events

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2 mar 2026, 20:05 UTC

Market Talk

Major News Events

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Peer Comparison

Price change

PROCEPT BioRobotics Corp Forecast

Price Target

By TipRanks

30.15% upside

12 Months Forecast

Average 33.71 USD 30.15%

High 60 USD

Low 20 USD

Based on 9 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to PROCEPT BioRobotics Corp - Dist in the past 3 months.

Technical Score

By Trading Central

52.655 / 56.31Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.